艾昆纬
IQV
查看详细走势图
221.700USD
-0.560-0.25%
交易中 （美东）报价延迟15分钟
37.76B总市值
30.23市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-0.25%
5天
-1.84%
1月
+0.49%
6月
+41.31%
今年开始到现在
+12.82%
1年
+11.37%
查看详细走势图
TradingKey 艾昆纬股票评分
单位: USD 更新时间: 2025-12-12操作建议
艾昆纬当前公司基本面数据相对稳定，增长潜力很大。当前估值合理，在生物技术与医疗研究行业排名7/404位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价249.55。中期看，股价处于上升通道。近一个月，市场表现一般，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
艾昆纬评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
25
位分析师
买入
评级
249.550
目标均价
+11.62%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
艾昆纬亮点
亮点风险
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
行业龙头
公司营业收入处于行业前列，最新年度总收入15.40B美元
利润高增长
公司净利润处于行业前列，最新年度总收入15.40B美元
估值合理
公司最新PE估值30.30，处于3年历史合理位
机构减仓
最新机构持股175.98M股，环比减少0.47%
HACAX持仓
明星投资者HACAX持仓，最新持仓市值2.79K
活跃度降低
近期活跃度降低，过去20天平均换手率-0.10
艾昆纬新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
艾昆纬简介
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
公司代码IQV
公司艾昆纬
CEOBousbib (Ari)
网址https://ir.iqvia.com/
常见问题
艾昆纬(IQV)的当前股价是多少？
艾昆纬(IQV)的当前股价是 221.700。
艾昆纬的股票代码是什么？
艾昆纬的股票代码是IQV。
艾昆纬股票的52周最高点是多少？
艾昆纬股票的52周最高点是234.295。
艾昆纬股票的52周最低点是多少？
艾昆纬股票的52周最低点是134.645。
艾昆纬的市值是多少？
艾昆纬的市值是37.76B。
艾昆纬的净利润是多少？
艾昆纬的净利润为1.37B。
现在艾昆纬(IQV)的股票是买入、持有还是卖出？
根据分析师评级，艾昆纬(IQV)的总体评级为买入，目标价格为249.550。
艾昆纬(IQV)股票的每股收益（EPS TTM）是多少
艾昆纬(IQV)股票的每股收益（EPS TTM）是7.335。
相关品种
